kabutan

Nxera Pharma, Apr-Jun (2Q) Net Income Loss Widens

Fri Aug 8, 2025 3:30 pm JST Earnings

4565 Nxera Pharma Co., Ltd. 【IFRS】

Earnings Report

Nxera Pharma Co., Ltd. <4565> [TSE Prime] announced its financial results (based on IFRS) after the market closed on August 8th (15:30). The consolidated net loss for the cumulative second quarter of the fiscal year ending December 2025 (January to June) was a reduced loss of 3.13 billion yen (compared to a loss of 4.70 billion yen in the same period last year).

In the most recent three-month period, from April to June (2Q), the consolidated net loss expanded to a loss of 2.37 billion yen (compared to a loss of 1.42 billion yen in the same period last year). However, the operating profit/loss margin improved from -7.1% in the same period last year to -6.7%.

Kabutan News

Actual Results

Accumulated Results 2nd Quarter
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Progress Rate vs. First Half Announce Accounting Standards
Jan - Jun, 2023 2,146 -4,168 -3,760 -2,060 -25.1 ー Aug 4, 2023 IFRS
Jan - Jun, 2024 12,720 -3,654 -3,158 -4,703 -52.5 ー Aug 9, 2024 IFRS
Jan - Jun, 2025 15,094 -2,756 -3,722 -3,137 -34.8 ー Aug 8, 2025 IFRS
YoY +18.7% +24.6% -17.9% +33.3% +33.7%

First Half Results vs. Previous Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Jan - Jun, 2025 Guidance ー ー ー ー － 0 Feb 14, 2025 IFRS
Jan - Jun, 2025 Results 15,094 -2,756 -3,722 -3,137 -34.8 0 Aug 8, 2025 IFRS
Revision Rate － － － － －

Current Period Guidance

Second Half Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Jul - Dec, 2024 16,115 -1,769 -1,504 -135 -1.5 0 Feb 14, 2025 IFRS
Jul - Dec, 2025 Guidance ー ー ー ー － 0 Feb 14, 2025 IFRS
YoY － － － － －

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Dec, 2023 12,766 -9,526 -10,680 -7,193 -87.2 0 Feb 13, 2024 IFRS
Dec, 2024 28,835 -5,423 -4,662 -4,838 -53.9 0 Feb 14, 2025 IFRS
Dec, 2025 Guidance ー ー ー ー － 0 Feb 14, 2025 IFRS
YoY － － － － －

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Apr - Jun, 2024 8,109 -578 -362 -1,422 -15.9 -7.1 Aug 9, 2024 IFRS
Jul - Sep, 2024 9,263 808 865 1,200 13.4 8.7 Nov 1, 2024 IFRS
Oct - Dec, 2024 6,852 -2,577 -2,369 -1,335 -14.9 -37.6 Feb 14, 2025 IFRS
Jan - Mar, 2025 6,644 -2,193 -2,156 -760 -8.5 -33.0 May 2, 2025 IFRS
Apr - Jun, 2025 8,450 -563 -1,566 -2,377 -26.4 -6.7 Aug 8, 2025 IFRS
YoY +4.2% +2.6% -332.6% -67.2% -66.1%

Related Articles